Jasper Therapeutics (JSPR) Other Working Capital Changes (2020 - 2025)

Jasper Therapeutics has reported Other Working Capital Changes for 6 years, with the latest figure at $3.0 million in Q4 2025.

• On a quarterly basis, Other Working Capital Changes rose 4.96% year-over-year to $3.0 million in Q4 2025; TTM through Dec 2025 was $1.8 million, a 16.2% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, down 16.2% from the prior year.
• Other Working Capital Changes was $3.0 million for Q4 2025 at Jasper Therapeutics, up from -$452000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $3.0 million in Q4 2025, with the low at -$1.0 million in Q3 2023.
• Average Other Working Capital Changes over 5 years is $232000.0, with a median of -$198500.0 recorded in 2022.
• The sharpest annual moves came in 2021 and 2023: Other Working Capital Changes jumped 13064.51% in 2021, then slumped 542.73% in 2023.
• Over 5 years, Other Working Capital Changes stood at -$403000.0 in 2021, then surged by 622.58% to $2.1 million in 2022, then tumbled by 71.42% to $602000.0 in 2023, then soared by 371.76% to $2.8 million in 2024, then grew by 4.96% to $3.0 million in 2025.
• The last three Other Working Capital Changes figures came in at $3.0 million (Q4 2025), -$452000.0 (Q3 2025), and -$435000.0 (Q2 2025), per Business Quant data.